Sex-based differences in pancreatic and biliary disease

Practical Gastroenterology

Volumn 30, Issue 4, 2006, Pages 49-67

  Jonnalagadda, Sreenivasa ^a   Janec, Eileen M ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; ESTRIOL; ESTRONE; GESTAGEN; PRASTERONE; PREGNENOLONE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ACALCULOUS CHOLECYSTITIS; ALGORITHM; BILIARY TRACT CANCER; BILIARY TRACT DISEASE; ESTROGEN INDUCED PANCREATITIS; FEMALE; HORMONE ACTION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS CANCER; PANCREAS DISEASE; PANCREATITIS; PATHOLOGICAL ANATOMY; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SEX DIFFERENCE;

EID: 33646571166     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology, 1999;117:632-639.
2. Williams CN, Johnson JL. Prevalence of gallstones and risk factors in Caucasian women in a rural Canadian community. Can Med Assoc J, 1980;122:664-668.
3. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest, 1991;87(1):237-246.
4. Angelin B, Olivecrona H, Reihnér E, Rudling M, Ståhlberg D, Eriksson M, Ewerth S, Henriksson, P, Einarsson K. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology, 1992;103:1657-1663.
5. Jensen KH, Jorgensen T. Incidence of gallstones in a Danish population. Gastroenterology, 1991;100:790-794.
6. Grodstein F, Colditz GA, Hunter DJ, et al. A prospective study of symptomatic gallstones in women: Relation with oral contraceptives and other risk factors. Obstet Gynecol, 1994;84:207-214.
7. Ranelletti FO, Piantelli M, Farinon AM, Zanella E, Capelli A. Estrogen and progesterone receptors in the gallbladders from patients with gallstones. Hepatology, 1991;14:608-612.
8. Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/Progestin Replacement Study. Ann Intern Med, 2001;135:493-501.
9. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest, 1991;87:237-246.
10. Bjorkman DJ, Burt RW, Tolman KG. Primary care of women with gastrointestinal disorders. Clin Obstet Gynecol, 1988;31:974-988.
11. Tilvis RS, Aro J, Strandberg TE, Lempinen M, Miettinen TA. Lipid composition of bile and gallbladder mucosa in patients with acalculous cholesterolosis. Gastroenterology, 1982;82(4):607-615.
12. Gordon RS, Forman S, Canner P, Berge K, Miller D. Gallbladder disease as a side effect of drugs influencing lipid metabolism. NEJM, 1977;296:1185-1190.
13. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males: relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest, 1989;84:811-816.
14. Thistle JL, Cleary PA, Lachin JM, et al. The natural history of cholelithiasis: The National Cooperative Gallstone Study. Ann Intern Med, 1984;101:171.
15. Newman HF, Northup JD, Rosenblum M, et al. Complications of cholelithiasis. Am J Gastroenterol, 1968;50:476.
16. Morrow DJ. Acute cholecystitis in the elderly. Arch Surg, 1978;113:1149-1152.
17. Taylor TV, Rimmer S, Holt S, Jeacock J, Lucas S. Sex differences in gallstone pancreatitis. Ann Surg, 1991;214(6):667-670.
18. Fried GM, Barkun JS, Sigman HH, Joseph L, Clas D, Garzon J, et al. Factors determining conversion to laparotomy in patients undergoing laparoscopic cholecystectomy. Am J Surgery, 1994; 167(1):35-41.
19. Ott DJ, Gilliam J, Zagoria RJ, et al. Interventional endoscopy of the biliary and pancreatic ducts: Current indications and methods. AJR Am J Roentgenol, 1992;158:243.
20. Hill LM, Johnson CE, Lee RA. Cholecystectomy in pregnancy. Obstet Gynecol, 1975;46:291-293.
21. Simon JA. Biliary tract disease and related surgical disorders during pregnancy, Clin Obstet Gynecol, 1983;26:810-821.
22. Zakim and Boyer. Hepatology: A Textbook of Liver Disease. 1996;3rd Edition:1734-1759.
23. De Graef CS, Grade M. Gallstones, pregnancy and ultrasound. Conn Med, 1979;43:424-425.
24. Jamidar PA, Beck GJ, Hoffman BJ, Lehman GA, Hawes RH, et al. Endoscopic Retrograde Cholangiopancreatography in Pregnancy. Am J Gastroenterol, 1995;90(8):1263-1267.
25. Muench J, Albrink M, Serafini F, Rosemurgy A, Carey L, Murr MM. Delay in treatment of biliary disease during pregnancy increases morbidity and can be avoided with safe laparoscopic cholecystectomy. Am Surgeon, 2001;67:539-542.
26. McKay AJ, O'Neill J, Imbrie CW. Pancreatitis, pregnancy and gallstones. Br J Obstet Gynecol, 1980;87:47-50.
27. Roberts IM. Gestational hyperlipidemic pancreatitis. Gastroenterol, 1993;104:1560.
28. Wilkinson EJ. Acute pancreatitis in pregnancy, a review of 93 cases and a report of 8 new cases. Obstet Gynecol Surg, 1973;28:281-303.
29. Fallat RW, Vester JW, Glueck CJ. Suppression of amylase activity by hypertriglyceridemia. JAMA, 1973;225:1331-1334.
30. Lesser PB, Warshaw AL. Diagnosis of pancreatitis masked by hyperlipidemia. Ann Intern Med, 1975;82:795-798.
31. Warshaw AL, Bellini CA, Lesser PB. Inhibition of serum and urine amylase activity in pancreatitis with hyperlipidemia. Ann Surg, 1975;182:72-75.
32. Jamidar PA, Beck GJ, Hoffman BJ, Lehman GA, Hawes RH, et al. Endoscopic Retrograde Cholangiopancreatography in Pregnancy. Am J Gastroenterol, 1995;90(8):1263-1267.
33. Tierney S, Qian Z, Yung B. Gender influences sphincter of Oddi response to cholecystokinin the prairie dog. Am J Physiol, 1995; 269:476-480.
34. Meshkinpour H, Mollot M. Bile duct dyskinesia and unexplained abdominal pain: a clinical and manometric study. Gastroenterol, 1987;92:1533A.
35. Hogan WJ, Geenen JE. Biliary dyskinesia. Endosc, 1988;20 (Suppl 1):179-183.
36. Sherman S,Troiano FP, Hawes RH, O'Connor KW,Lehman GA. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of Oddi dysfunction. Am J Gastroenterol, 1991;86:586-590.
37. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. NEJM, 1996;335:909.
38. Moreau JA, Zinsmeister AR, Melton LJIII, DiMagno EP. Gallstone pancreatitis and the effect of cholecystectorny. a population based cohort study. Mayo Clin Proc, 1988;63:466-473.
39. Taylor TV, Rimmer S. Pancreatic duct reflux in patients with gallstone pancreatitis? Lancet, 1980;1:848-851.
40. Diehl AK, Holleman Jr DR, Chapman JB, et al. Gallstone size and risk of pancreatitis. Arch Intern Med, 1997:157;1674.
41. Taylor TV, Rimmer S, Holt S, Jeacock J, Lucas S. Sex Differences in Gallstone Pancreatitis. Ann Surg, 1991;214(6):667-670.
42. Bank S, Marks IN. Hyperlipademic pancreatitis and the pill. Postgrad Med J, 1970;46:576-588.
43. Mallory A, Kern Jr F. Drug-induced pancreatitis: A Critical Review. Gastroenterology, 1980;78:813-820.
44. Ganepola GAP, Gritsman AY, Asimakopulos N, Yiengpruksawan A. Are pancreatic tumors hormone dependent? Am Surg, 1999;65:105-111.
45. Greenway B, Iqbal MJ, Johnson PJ, Williams R. Estrogen receptor proteins I malignant and fetal pancreas. Br Med J Res, 1981;283:751-753.
46. Andren-Sandberg A. Androgen influence on exocrine pancreatic cancer. Int J Pancreatol, 1989;4:363-369.
47. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer, 1998;12(34):2271-2278.
48. McMillen MM. Differential mortality by sex in fetal and neonatal deaths. Science, 1979;204:89-91.
49. Wiersema MJ, Vilmann P, Giovanni, M, et al. Endosonography-guided fine needle aspiration biopsy: Diagnostic accuracy and complication assessment. Gastroenterology, 1997;112:1087-1095.
50. Ritts RE. Pitt HA. CA 19-9 in pancreatic cancer. Surg Oncol Clin North AM, 1998;7:93-100.
51. Birkmeyer JD, Finlayson SRG, Tosteson ANA, et al. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery, 1999;1255:250-256.
52. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas in 616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg, 2000;4:567-579.